LLY vs. ABBV
Compare and contrast key facts about Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LLY or ABBV.
Correlation
The correlation between LLY and ABBV is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LLY vs. ABBV - Performance Comparison
Key characteristics
LLY:
0.27
ABBV:
0.27
LLY:
0.65
ABBV:
0.52
LLY:
1.08
ABBV:
1.08
LLY:
0.39
ABBV:
0.36
LLY:
0.81
ABBV:
0.91
LLY:
11.97%
ABBV:
8.06%
LLY:
36.12%
ABBV:
26.90%
LLY:
-68.27%
ABBV:
-45.09%
LLY:
-14.50%
ABBV:
-20.74%
Fundamentals
LLY:
$754.27B
ABBV:
$306.02B
LLY:
$11.68
ABBV:
$2.39
LLY:
71.91
ABBV:
72.38
LLY:
1.22
ABBV:
0.38
LLY:
16.75
ABBV:
5.43
LLY:
53.15
ABBV:
92.03
LLY:
$36.27B
ABBV:
$44.02B
LLY:
$29.53B
ABBV:
$33.24B
LLY:
$12.51B
ABBV:
$12.60B
Returns By Period
In the year-to-date period, LLY achieves a 6.14% return, which is significantly higher than ABBV's -2.45% return. Over the past 10 years, LLY has outperformed ABBV with an annualized return of 30.07%, while ABBV has yielded a comparatively lower 14.65% annualized return.
LLY
6.14%
-2.33%
-9.42%
13.36%
41.07%
30.07%
ABBV
-2.45%
-18.23%
-7.07%
5.97%
20.81%
14.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LLY vs. ABBV — Risk-Adjusted Performance Rank
LLY
ABBV
LLY vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LLY vs. ABBV - Dividend Comparison
LLY's dividend yield for the trailing twelve months is around 0.66%, less than ABBV's 3.75% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.66% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
ABBV AbbVie Inc. | 3.75% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
LLY vs. ABBV - Drawdown Comparison
The maximum LLY drawdown since its inception was -68.27%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for LLY and ABBV. For additional features, visit the drawdowns tool.
Volatility
LLY vs. ABBV - Volatility Comparison
Eli Lilly and Company (LLY) has a higher volatility of 18.68% compared to AbbVie Inc. (ABBV) at 11.82%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LLY vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Eli Lilly and Company and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities